Psychopharmacology of ADHD
Deepening Clinician Insight into Medication Strategies
- Speaker:
- Stephanie L. Shafer, DHSc, MSN, PMHNP-BC, ANP-BC
- Duration:
- 2 Hours 03 Minutes
- Format:
- Audio and Video
- Copyright:
-
Mar 21, 2024
- Product Code:
- POS078750
- Media Type:
- Digital Seminar
Description
Stephanie Shafer, MSN, ANP-BC, PMHNP-BC, will deliver an advanced and updated review of stimulant (e.g., methylphenidate, amphetamines) and non-stimulant (e.g., atomoxetine, guanfacine) medications, with a particular focus on understanding the mechanisms of action, how they differ, and how one might synergistically compliment another. Learn how these medications affect the brain’s chemistry and function to alleviate ADHD symptoms, allowing for a deeper appreciation of their therapeutic potential. Central to the discussion will be the identification of presenting symptomatology and the evaluating of treatment outcomes. This focus will provide the knowledge and skills needed to adeptly navigate the evolving landscape of ADHD management.
By the talk’s conclusion, you will possess a robust understanding of ADHD’s neurobiological basis, as well as a comprehensive knowledge of the mechanisms by which available medications act. Deliver personalizing care for patients with ADHD to enhance their quality of life and daily functioning to the future.
Credit
Speaker
Stephanie L. Shafer, DHSc, MSN, PMHNP-BC, ANP-BC Related seminars and products
Stephanie Shafer, DHSc, MSN, PMHNP-BC, ANP-BC, founded Neurobehavioral Health and Wellness, a private mental health practice in Okemos, Michigan, recognized as the "Best Mental Health Clinic" several years in a row. The practice serves adults, adolescents, and children with psychiatric disorders, including ADHD, bipolar disorder, depression, anxiety, obsessive-compulsive tendencies, schizophrenia, autism spectrum disorder, traumatic brain injury, PTSD, and personality disorders.
Central to her success is a structured model of care built around thorough clinical and background histories, careful identification of psychosocial stressors, and a mechanism-based approach to treatment - a framework that has proven essential to the effective delivery of psychiatric medications within her practice.
Clinically, Dr. Shafer's background spans emergency medicine, primary care, and psychiatry, across settings ranging from a large urban hospital to community-based practices, clinics, and private practice. A transition from primary care to psychiatry followed naturally, driven by a commitment to serving a growing population of underserved patients with psychiatric disorders. The past decade has been devoted to refining her skills in outpatient psychiatry.
She has completed graduate studies at UCLA, followed by a specialized post-master's degree in psychiatric mental health from The Johns Hopkins University in Baltimore, MD. Dual certification as a nurse practitioner and an NEI Master Psychopharmacology certification round out her clinical accomplishments. In demand as a speaker, she regularly shares her expertise with multidisciplinary healthcare audiences nationwide, including resident physicians at Michigan State University.
Speaker Disclosures:
Financial: Stephanie Shafer maintains a private practice and receives a speaking honorarium from Collegium pharmaceuticals. She receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Stephanie Shafer is a member of the American Association of Nurse Practitioners.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Explain the key neurobiological factors involved in ADHD, including neurotransmitter systems, brain regions implicated, and how they contribute to the symptoms of the disorder.
- Evaluate the pharmacological treatments available for ADHD, including stimulant medications (e.g., methylphenidate, amphetamines) and non-stimulant mediations (e.g., atomoxetine, guanfacine).
- Differentiate ADHD from common differentials and tailor pharmacotherapy to individual patients.
- Analyze the effectiveness of ADHD medications, while also considering potential side effects.
Outline
Neurobiology of ADHD- Neurotransmitter systems
- Brain regions implicated
- Contribution to symptoms
- Stimulant medications
- Methylphenidate
- Amphetamines
- Non-stimulant medications
- Atomoxetine
- Guanfacine, etc.
- Mechanisms of action
- Efficacy and effectiveness
- Differences and combinations
- Differential diagnosis
- Distinguish ADHD from common differentials
- Consideration of comorbid psychiatric conditions
- Tailoring pharmacotherapy
- Customize treatment plans based on individual patient profiles
- Adjust dosage and medication type as needed
- Address overlapping symptomatology
- Strategies to manage symptoms that overlap with other disorders
- Coordinate care with other healthcare providers
- Effectiveness of Medications
- Reduction of ADHD symptoms
- Improvement in daily functioning
- Cognitive and emotional beliefs
- Side Effects
- Common side effects of ADHD medications
- Strategies to minimize side effects
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...